Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Gross Profit: 2020-2024

Historic Gross Profit for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $35.3 million.

  • Journey Medical's Gross Profit rose 16.91% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year decrease of 0.22%. This contributed to the annual value of $35.3 million for FY2024, which is 37.37% down from last year.
  • Latest data reveals that Journey Medical reported Gross Profit of $35.3 million as of FY2024, which was down 37.37% from $56.3 million recorded in FY2023.
  • Journey Medical's 5-year Gross Profit high stood at $56.3 million for FY2023, and its period low was $29.9 million during FY2020.
  • Moreover, its 3-year median value for Gross Profit was $42.9 million (2022), whereas its average is $44.8 million.
  • Its Gross Profit has fluctuated over the past 5 years, first spiked by 38.14% in 2022, then crashed by 37.37% in 2024.
  • Yearly analysis of 5 years shows Journey Medical's Gross Profit stood at $29.9 million in 2020, then climbed by 3.72% to $31.1 million in 2021, then soared by 38.14% to $42.9 million in 2022, then skyrocketed by 31.23% to $56.3 million in 2023, then slumped by 37.37% to $35.3 million in 2024.